95 related articles for article (PubMed ID: 7504038)
1. [Clinical study of heart rate abnormality--special reference to myocardial ion channels].
Mashiba H
Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1331-40. PubMed ID: 7504038
[No Abstract] [Full Text] [Related]
2. [Current classification of anti-arrhythmia agents].
Weirich J; Wenzel W
Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
[TBL] [Abstract][Full Text] [Related]
3. Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti-arrhythmic principle?
Grunnet M
Acta Physiol (Oxf); 2010 Feb; 198 Suppl 676():1-48. PubMed ID: 20132149
[TBL] [Abstract][Full Text] [Related]
4. QT prolongation modifies dynamic restitution and hysteresis of the beat-to-beat QT-TQ interval relationship during normal sinus rhythm under varying states of repolarization.
Fossa AA; Wisialowski T; Crimin K
J Pharmacol Exp Ther; 2006 Feb; 316(2):498-506. PubMed ID: 16204470
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic considerations in diseases of cardiac ion channels.
Anantharam A; Markowitz SM; Abbott GW
J Pharmacol Exp Ther; 2003 Dec; 307(3):831-8. PubMed ID: 14561846
[TBL] [Abstract][Full Text] [Related]
6. Cardiac electrophysiological effects of nitric oxide.
Tamargo J; Caballero R; Gómez R; Delpón E
Cardiovasc Res; 2010 Sep; 87(4):593-600. PubMed ID: 20587506
[TBL] [Abstract][Full Text] [Related]
7. [Prolonged QT(U) interval: association with disease and use of drugs].
Laakso M; Aberg A; Savola J; Pentikäinen PJ; Pyörälä K
Duodecim; 1986; 102(4):235-42. PubMed ID: 3956410
[No Abstract] [Full Text] [Related]
8. Assessment of cardiac autonomic regulation and ventricular repolarization after off-pump coronary artery bypass grafting.
Kalisnik JM; Avbelj V; Trobec R; Ivaskovic D; Vidmar G; Troise G; Gersak B
Heart Surg Forum; 2006; 9(3):E661-7. PubMed ID: 16753938
[TBL] [Abstract][Full Text] [Related]
9. Channel structure and drug-induced cardiac arrhythmias.
Kass RS; Cabo C
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):11683-4. PubMed ID: 11050193
[No Abstract] [Full Text] [Related]
10. Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias.
Furukawa T; Kurokawa J
Pharmacol Ther; 2007 Jul; 115(1):106-15. PubMed ID: 17583354
[TBL] [Abstract][Full Text] [Related]
11. [Potassium channels and arrhythmia].
Funck-Brentano C
Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():9-13. PubMed ID: 1307198
[TBL] [Abstract][Full Text] [Related]
12. [Cardiac arrhythmias (III). The classification of anti-arrhythmia drugs in the 90s: a focus for the cardiologist].
Tamargo J; Valenzuela C; Delpón E
Rev Esp Cardiol; 1993 Mar; 46(3):183-94. PubMed ID: 8387683
[No Abstract] [Full Text] [Related]
13. [Failure of antiarrhythmia agents and understanding the phenomenon of proarrhythmia].
Semrád B
Vnitr Lek; 2003 Sep; 49(9):700-6. PubMed ID: 14584417
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
Du Toit EF; Muller CA; McCarthy J; Opie LH
J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
[TBL] [Abstract][Full Text] [Related]
15. [Role of the sympathetic nervous system in the protective effect of the selective kappa-opiate agonist dynorphin A(1-13) on frequency of cardiac arrhythmias during myocardial ischemia].
Mikhaĭlova SD; Vasil'eva TV; Semushkina TM; Storozhakov GI
Biull Eksp Biol Med; 2000 Jan; 129(1):34-7. PubMed ID: 10710623
[No Abstract] [Full Text] [Related]
16. Protective effects of taurine against reperfusion-induced arrhythmias in isolated ischemic rat heart.
Chahine R; Feng J
Arzneimittelforschung; 1998 Apr; 48(4):360-4. PubMed ID: 9608877
[TBL] [Abstract][Full Text] [Related]
17. Blockade of myocardial slow channels by bepridil (CERM-1978).
Vogel S; Crampton R; Sperelakis N
J Pharmacol Exp Ther; 1979 Sep; 210(3):378-85. PubMed ID: 480188
[No Abstract] [Full Text] [Related]
18. The clinical utility of QT interval assessment in diabetes.
Veglio M; Chinaglia A; Cavallo Perin P
Diabetes Nutr Metab; 2000 Dec; 13(6):356-65. PubMed ID: 11232762
[TBL] [Abstract][Full Text] [Related]
19. Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin.
Gandhi C; Upaganalawar A; Balaraman R
Free Radic Res; 2009 Sep; 43(9):817-27. PubMed ID: 19579067
[TBL] [Abstract][Full Text] [Related]
20. Funny channel-based pacemaking.
DiFrancesco D
Heart Rhythm; 2010; 7(2):276-9. PubMed ID: 20022815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
